CINECA IRIS Institutional Research Information System

PAPOTTI, Mauro Giulio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 25.190
EU - Europa 17.191
AS - Asia 9.834
SA - Sud America 692
OC - Oceania 275
AF - Africa 241
Continente sconosciuto - Info sul continente non disponibili 32
Totale 53.455
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.364
CN - Cina 4.751
IT - Italia 3.963
IE - Irlanda 1.862
DE - Germania 1.823
FR - Francia 1.542
SE - Svezia 1.493
UA - Ucraina 1.260
SG - Singapore 1.176
GB - Regno Unito 1.026
FI - Finlandia 1.011
KR - Corea 936
CA - Canada 656
JP - Giappone 647
PL - Polonia 609
IN - India 607
AT - Austria 601
VN - Vietnam 452
BR - Brasile 387
ES - Italia 383
TR - Turchia 316
NL - Olanda 285
AU - Australia 247
DK - Danimarca 217
ID - Indonesia 211
BE - Belgio 171
RU - Federazione Russa 169
HK - Hong Kong 161
GR - Grecia 152
MX - Messico 150
TW - Taiwan 124
AR - Argentina 120
CH - Svizzera 114
RO - Romania 100
PT - Portogallo 98
SN - Senegal 85
CO - Colombia 71
CZ - Repubblica Ceca 68
IL - Israele 60
PH - Filippine 51
CL - Cile 50
SA - Arabia Saudita 50
NO - Norvegia 49
TH - Thailandia 46
HU - Ungheria 44
PK - Pakistan 43
MY - Malesia 42
EG - Egitto 35
UZ - Uzbekistan 35
EU - Europa 31
HR - Croazia 29
RS - Serbia 29
ZA - Sudafrica 28
DZ - Algeria 27
IR - Iran 27
NZ - Nuova Zelanda 27
SI - Slovenia 25
AE - Emirati Arabi Uniti 23
PE - Perù 21
EC - Ecuador 19
SK - Slovacchia (Repubblica Slovacca) 17
VE - Venezuela 15
MU - Mauritius 13
BG - Bulgaria 11
MA - Marocco 11
NG - Nigeria 11
AM - Armenia 10
IQ - Iraq 9
TN - Tunisia 9
BY - Bielorussia 8
JO - Giordania 8
KZ - Kazakistan 8
MK - Macedonia 8
GT - Guatemala 6
BA - Bosnia-Erzegovina 5
PR - Porto Rico 5
SC - Seychelles 5
SD - Sudan 5
CY - Cipro 4
LB - Libano 4
LU - Lussemburgo 4
OM - Oman 4
PY - Paraguay 4
QA - Qatar 4
SY - Repubblica araba siriana 4
UY - Uruguay 4
BD - Bangladesh 3
EE - Estonia 3
GE - Georgia 3
KW - Kuwait 3
LK - Sri Lanka 3
LV - Lettonia 3
PA - Panama 3
CI - Costa d'Avorio 2
CU - Cuba 2
MT - Malta 2
PS - Palestinian Territory 2
RE - Reunion 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
Totale 53.428
Salva come PNG Salva come JPEG
Città #
Chandler 2.630
Beijing 2.556
Dublin 1.828
Houston 1.749
Fairfield 1.447
Ann Arbor 1.087
Ashburn 1.019
Torino 930
Wilmington 869
Singapore 820
Jacksonville 819
Redwood City 800
Villeurbanne 751
Woodbridge 741
Seattle 617
Medford 597
Princeton 578
Vienna 565
Nyköping 515
Cambridge 514
Dearborn 488
Warsaw 481
Pisa 423
Fremont 326
Milan 307
Boston 283
Turin 251
Shanghai 239
Guangzhou 234
Dong Ket 225
New York 213
Boardman 192
Jakarta 179
Nanjing 179
Toronto 168
Tokyo 164
Verona 146
Hangzhou 137
Munich 132
Santa Clara 124
Rome 116
Seoul 112
Norwalk 105
Pune 105
Chicago 104
San Diego 100
Washington 96
Düsseldorf 93
Montréal 90
Helsinki 86
Brussels 85
Chengdu 79
Tappahannock 79
Madrid 76
London 75
Falls Church 74
Wuhan 71
Los Angeles 70
São Paulo 68
Hefei 67
Lachine 67
Zhengzhou 67
Phoenix 66
Taipei 66
Würzburg 66
Paris 65
Shenyang 64
Bologna 63
Mcallen 63
Mountain View 62
Jinan 61
Ottawa 57
Kunming 56
Pittsburgh 55
Silver Spring 55
Buenos Aires 54
Ankara 51
Changsha 51
Rochester 51
Istanbul 49
Athens 48
New Delhi 48
Central District 47
Santiago 43
Dallas 42
Hebei 42
Birmingham 41
Barcelona 40
Bethesda 40
Amsterdam 39
Hong Kong 39
Padova 39
Canberra 38
Honolulu 38
Moscow 38
Florence 36
Philadelphia 36
Chongqing 34
Lexington 34
Nanchang 34
Totale 30.059
Salva come PNG Salva come JPEG
Nome #
The weiss score and beyond--histopathology for adrenocortical carcinoma. 1.369
The Reticulin Algorithm for Adrenocortical Tumor Diagnosis: A Multicentric Validation Study on 245 Unpublished Cases. 1.069
CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma 1.023
Cytological features of "noninvasive follicular thyroid neoplasm with papillary-like nuclear features" and their correlation with tumor histology 872
Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection. 780
Validation of the prognostic role of the "Helsinki Score" in 225 cases of adrenocortical carcinoma 665
Adrenocortical tumors with myxoid features: a distinct morphologic and phenotypical variant exhibiting malignant behavior. 655
What clinicians are asking pathologists when dealing with lung neuroendocrine neoplasms? 580
β1 integrin controls EGFR signaling and tumorigenic properties of lung cancer cells. 511
Ki-67 labeling index of neuroendocrine tumors of the lung has a high level of correspondence between biopsy samples and surgical specimens when strict counting guidelines are applied 459
Morgana acts as an oncosuppressor in chronic myeloid leukemia. 433
Eccrine spiradenoma of the nipple: Case report, differential diagnosis and literature review 424
Oncocytic Adrenocortical Tumors: Diagnostic Algorithm and Mitochondrial DNA Profile in 27 Cases. 423
Phosphorylated ERalpha, HIF-1alpha, and MAPK signaling as predictors of primary endocrine treatment response and resistance in patients with breast cancer 423
Tumor staging but not grading is associated with adverse clinical outcome in neuroendocrine tumors of the appendix: a retrospective clinical pathologic analysis of 138 cases. 412
Renal oncocytosis: a clinicopathological and cytogenetic study of 42 tumours occurring in 11 patients 404
Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart 386
Napsin-A, TTF-1, EGFR, and ALK Status Determination in Lung Primary and Metastatic Mucin-Producing Adenocarcinomas 373
Extrapulmonary neuroendocrine small and large cell carcinomas: a review of controversial diagnostic and therapeutic issues. 372
Obestatin regulates adipocyte function and protects against diet-induced insulin resistance and inflammation. 370
The roles of multiparametric magnetic resonance imaging, PCA3 and prostate health index - Which is the best predictor of prostate cancer after a negative biopsy? 335
Most high-grade neuroendocrine tumours of the lung are likely to secondarily develop from pre-existing carcinoids: innovative findings skipping the current pathogenesis paradigm 331
RAS mutations are the predominant molecular alteration in poorly differentiated thyroid carcinomas and bear prognostic impact 329
Clinicopathological study of a series of 92 adrenocortical carcinomas: from a proposal of simplified diagnostic algorithm to prognostic stratification. 318
Expression of ghrelin and biological activity of specific receptors for ghrelin and des-acyl ghrelin in human prostate neoplasms and related cell lines 317
Molecular and Histological Changes in Post-Treatment Biopsies of Non-Squamous Non-Small Cell Lung Cancer: A Retrospective Study 316
Prognostic Role of Overt Hypercortisolism in Completely Operated Patients with Adrenocortical Cancer 314
Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors 312
microRNA expression patterns in adrenocortical carcinoma variants and clinical pathologic correlations 306
Mesothelioma families without inheritance of a BAP1 predisposing mutation 301
Therapeutic Biomarkers in Lung Neuroendocrine Neoplasia 295
Detection of EGFR mutations in archival lung cancer samples by pyrosequencing 293
An international Ki67 reproducibility study in adrenal cortical Carcinoma 288
Core biopsies of renal masses: a safe and accurate tool for managing all that is indeterminate 285
The Third Italian Consensus Conference for Malignant Pleural Mesothelioma: State of the art and recommendations 285
Pathology of the Adrenal Cortex: a Reappraisal of the Past 25 Years Focusing on Adrenal Cortical Tumors. 271
Poorly differentiated thyroid carcinoma: 5 years after the 2004 WHO classification of endocrine tumours. 269
Sarcomatoid adrenocortical carcinoma: a comprehensive pathological, immunohistochemical, and targeted next-generation sequencing analysis 265
Targeted next-generation sequencing of cancer genes in advanced stage malignant pleural mesothelioma: a retrospective study. 264
Diagnostic and prognostic role of steroidogenic factor 1 in adrenocortical carcinoma: a validation study focusing on clinical and pathologic correlates 263
The potential of combined immunotherapy and antiangiogenesis for the synergistic treatment of advanced NSCLC. 259
Somatostatin receptor tissue distribution in lung neuroendocrine tumours: a clinicopathologic and immunohistochemical study of 218 'clinically aggressive' cases. 250
Expression of cortistatin and MrgX2, a specific cortistatin receptor, in human neuroendocrine tissues and related tumours 249
Potential diagnostic and prognostic role of micro-environment in malignant pleural mesothelioma 248
RRM1 modulates mitotane activity in adrenal cancer cells interfering with its metabolization 246
Adjuvant mitotane treatment for adrenocortical carcinoma 241
Mammalian target of rapamycin pathway activation is associated to RET mutation status in medullary thyroid carcinoma. 236
MEN1 Gene Mutation and Reduced Expression Are Associated with Poor Prognosis in Pulmonary Carcinoids 231
Differential expression of HER2, STAT3, SOX2, IFI16 and cell cycle markers during HPV-related head and neck carcinogenesis 229
Cytotoxic activity of gemcitabine, alone or in combination with mitotane, in adrenocortical carcinoma cell lines. 228
Morgana is a new oncosuppressor in CML 226
Comparative diagnostic and prognostic performances of the hematoxylin-eosin and phospho-histone H3 mitotic count and Ki-67 index in adrenocortical carcinoma 224
Retrospective multicenter study investigating the role of targeted next-generation sequencing of selected cancer genes in mucinous adenocarcinoma of the lung 222
Effects of sub-chronic nandrolone administration on hormonal adaptive response to acute stress in rats. 215
Validation of the diagnosis of mesothelioma and BAP1 protein expression in a cohort of asbestos textile workers from Northern Italy 208
Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer 206
ELOVL5 Mutations Cause Spinocerebellar Ataxia 38 202
Optimal Ki67 cut-off for luminal breast cancer prognostic evaluation: a large case series study with a long-term follow-up 201
YKL-40/c-Met Expression in Rectal Cancer Biopsies Predicts Tumor Regression following Neoadjuvant Chemoradiotherapy: A Multi-Institutional Study 199
ATF2 contributes to cisplatin resistance in non-small cell lung cancer and celastrol induces cisplatin resensitization through inhibition of JNK/ATF2 pathway. 193
mTORC1 Complex is Significantly Over-Activated in SDHX-Mutated Paragangliomas 190
Outcome of patients with severe AL amyloidosis and biopsy-proven renal involvement ineligible for bone marrow transplantation 190
Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical Carcinoma 189
Differentiation-inducing factor 1 enhances 5-fluorouracil action on oral cancer cells inhibiting E2F1 and Thymidylate Synthase mRNAs accumulation 187
Dasatinib modulates sensitivity to pemetrexed in malignant pleural mesothelioma cell lines 187
H-RAS mutations are restricted to sporadic pheochromocytomas lacking specific clinical or pathological features data from a multi-institutional series 186
Brca1-Associated Protein 1 (BAP1) Immunohistochemical Expression as a Diagnostic Tool in Malignant Pleural Mesothelioma Classification: a Large Retrospective Study 185
Distinctive pathological and clinical features of lung carcinoids with high proliferation index 183
Impact of COVID-19 lockdown measures on oncological surgical activity: Analysis of the surgical pathology caseload of a tertiary referral hospital in Northwestern Italy 177
Mammalian target of rapamycin signaling activation patterns in neuroendocrine tumors of the lung. 175
Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma 174
Why castration-resistant prostate cancer patients with neuroendocrine differentiation should be addressed to a cisplatin-based regimen 172
Detection and characterization of classical and "uncommon" exon 19 Epidermal Growth Factor Receptor mutations in lung cancer by pyrosequencing 171
Anticoagulation in patients with concomitant lupus nephritis and thrombotic microangiopathy: A multicentre cohort study 169
Effects of Src kinase inhibition induced by dasatinib in non-small cell lung cancer cell lines treated with cisplatin 164
Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: the xelbevoct study. 164
Retrospective study testing next generation sequencing of selected cancer-associated genes in resected prostate cancer 163
Increased neuroendocrine cells in resected metastases compared to primary colorectal adenocarcinomas. 161
Utilility of flow cytometry as ancillary study to improve the cytologic diagnosis of thyroid lymphomas 161
CAVEOLIN-1 expression in brain metastasis from lung cancer predicts worse outcome and radioresistance, irrespective of tumor histotype 159
Ki-67 proliferation index but not mitotic thresholds integrates the molecular prognostic stratification of lower grade gliomas 159
A DNA vaccine against ERBB2 impairs chemical carcinogenesis in random-bred hamsters 156
ACYLATED AND UNACYLATED GHRELIN PROMOTE PROLIFERATION AND INHIBIT SERUM STARVATION- AND CYTOKINE-INDUCED APOPTOSIS OF PANCREATIC BETA-CELLS AND HUMAN ISLETS. INVOLVEMENT OF cAMP/PKA, ERK1/2 AND PI3K/AKT SIGNALING 156
Precision medicine in age-specific non-small-cell-lung-cancer patients: Integrating biomolecular results into clinical practice-A new approach to improve personalized translational research. 148
ALK Rearrangement Testing by FISH Analysis in Non-Small-Cell Lung Cancer Patients: Results of the First Italian External Quality Assurance Scheme. 146
Aurora Kinase A expression is associated with lung cancer histological-subtypes and with tumor de-differentiation. 145
Large cell carcinoma of the lung: A tumor in search of an author. A clinically oriented critical reappraisal 144
SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: A multicenter interobserver variation analysis using virtual microscopy: A Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T) 144
Progressive increase of matrix metalloprotease-9 and interleukin-8 serum levels during carcinogenic process in human colorectal tract 142
Inhibition of human respiratory syncytial virus infectivity by a dendrimeric heparan sulfate-binding peptide. 140
Classification of pulmonary neuroendocrine tumors: New insights 136
mTOR/p70S6K in Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia. 135
Current state-of-the-art therapy for advanced squamous cell lung cancer 133
Synergistic activation upon MET and ALK coamplification sustains targeted therapy in sarcomatoid Carcinoma, a deadly subtype of lung cancer 131
Impact of non-small-cell lung cancer-not otherwise specified immunophenotyping on treatment outcome. 130
Safety and diagnostic performance of image-guided lung biopsy in the targeted therapy era 127
RFamide peptides 43RFa and 26RFa both promote survival of pancreatic β-cells and human pancreatic islets but exert opposite effects on insulin secretion. 126
PAX8–GLIS3 gene fusion is a pathognomonic genetic alteration of hyalinizing trabecular tumors of the thyroid 126
CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer 125
CYP2W1 Is Highly Expressed in Adrenal Glands and Is Positively Associated with the Response to Mitotane in Adrenocortical Carcinoma 123
Totale 28.752
Salva come PNG Salva come JPEG
Categoria #
all - tutte 148.987
article - articoli 0
book - libri 0
conference - conferenze 10.732
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 159.719
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207.989 0 0 593 949 748 1.441 1.002 655 856 713 615 417
2020/20216.665 578 455 587 389 591 495 602 376 667 623 489 813
2021/20226.619 336 377 372 474 358 349 478 412 287 469 1.334 1.373
2022/20239.107 924 626 227 882 857 2.266 714 576 974 249 460 352
2023/20244.783 588 779 340 276 323 591 208 276 58 278 399 667
2024/20251.508 221 892 395 0 0 0 0 0 0 0 0 0
Totale 55.333